SCHEDULE: Maravai LifeSciences: Group Discloses 7.23% Stake

A group of investors, including Stuart Feldman, Matthew Barkoff, and Joshua Wool, along with associated entities, reported a collective beneficial ownership of 7.23% in Maravai LifeSciences Holdings, Inc. Class A Common Stock.

Summary

• A group of reporting persons, including Hudson View Holdings LLC, Hudson View Capital LLC, JD Squared Holdings II LLC, JD Squared Capital II LLC, Stuart Feldman, Matthew Barkoff, and Joshua Wool, collectively beneficially own 10,486,451 shares of Maravai LifeSciences Holdings, Inc. Class A Common Stock.
• This aggregate ownership represents 7.23% of the Class A Common Stock.
• Stuart Feldman has sole voting and dispositive power over 7,979,802 shares, representing 5.5% of the class.
• Matthew Barkoff has sole voting and dispositive power over 2,251,649 shares, representing 1.55% of the class.
• Joshua Wool has sole voting and dispositive power over 255,000 shares, representing 0.18% of the class.
• The filing is an Amendment No. 2 to a Schedule 13G, indicating a change from a previous filing.
• The securities were not acquired or held for the purpose of changing or influencing control of the issuer, other than activities solely in connection with a nomination under Rule 14a-11.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it primarily reports a factual ownership stake without providing operational or financial performance updates. The disclaimer regarding control influence suggests a passive investment.

Future Outlook

NA

Management Comments

• The securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under Rule 14a-11.

Industry Context

StockSavvy.ai notes that Schedule 13G filings provide transparency into significant ownership stakes, which can sometimes signal investor confidence or potential activist interest, though this filing explicitly disclaims intent to influence control.

Stakeholder Impact

• Shareholders: Increased transparency regarding significant ownership, potentially signaling confidence from a large investor group.

Key Dates

Keywords

Maravai LifeSciences, Class A Common Stock, Schedule 13G, beneficial ownership, Hudson View Holdings, Hudson View Capital, JD Squared Holdings, JD Squared Capital, Stuart Feldman, Matthew Barkoff, Joshua Wool, equity stake, institutional ownership, SEC filing